» Articles » PMID: 33643695

B-cell Clusters at the Invasive Margin Associate with Longer Survival in Early-stage Oral-tongue Cancer Patients

Overview
Journal Oncoimmunology
Date 2021 Mar 1
PMID 33643695
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In oral-cancer, the number of tumor-infiltrating lymphocytes (TILs) associates with improved survival, yet the prognostic value of the cellular composition and localization of TILs is not defined. We quantified densities, localizations, and cellular networks of lymphocyte populations in 138 patients with T1-T2 primary oral-tongue squamous cell carcinoma treated with surgical resections without any perioperative (chemo)radiotherapy, and correlated outcomes to overall survival (OS). Multiplexed in-situ immunofluorescence was performed for DAPI, CD4, CD8, CD20, and pan-cytokeratin using formalin-fixed paraffin-embedded sections, and spatial distributions of lymphocyte populations were assessed in the tumor and stroma compartments at the invasive margin (IM) as well as the center of tumors. We observed a high density of CD4, CD8, and CD20 cells in the stroma compartment at the IM, but neither lymphocyte densities nor networks as single parameters associated with OS. In contrast, assessment of two contextual parameters within the stroma IM region of tumors, i.e., the number of CD20 cells within 20 µm radii of CD20 and CD4 cells, termed the , yielded a highly significant association with OS (HR 0.38; = .003). Notably, the significantly correlated with better OS and disease-free survival in multivariate analysis (HR 0.34 and 0.47; = .001 and 0.019) as well as with lower local recurrence rate (OR: 0.13; = .028). Taken together, our study showed that the presence of stromal B-cell clusters at IM, in the co-presence of CD4 T-cells, associates with good prognosis in early oral-tongue cancer patients.

Citing Articles

The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review.

Ribeiro V, Teillaud J, Dieu-Nosjean M, Lescaille G, Rochefort J Front Oral Health. 2025; 5:1524313.

PMID: 39911478 PMC: 11794802. DOI: 10.3389/froh.2024.1524313.


Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease.

Nauta I, Nijenhuis D, Ganzevles S, Raaff P, Kloosterman J, Bloemena E Cancers (Basel). 2025; 17(1.

PMID: 39796740 PMC: 11719715. DOI: 10.3390/cancers17010113.


ALOA, a pipeline for preliminary analysis of spatial profiling imaging data.

Parrillo C, Persiani F, Mantini G, Cellini B, DAmati A, Lucchetti D Comput Struct Biotechnol J. 2024; 23:4143-4147.

PMID: 39640532 PMC: 11617886. DOI: 10.1016/j.csbj.2024.11.029.


Revealing molecular mechanisms of early-onset tongue cancer by spatial transcriptomics.

Patysheva M, Kolegova E, Khozyainova A, Prostakishina E, Korobeynikov V, Menyailo M Sci Rep. 2024; 14(1):26255.

PMID: 39482351 PMC: 11528053. DOI: 10.1038/s41598-024-76044-2.


Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.

Xin S, Wen S, He P, Zhao Y, Zhao H Front Immunol. 2024; 15:1423775.

PMID: 39192984 PMC: 11347756. DOI: 10.3389/fimmu.2024.1423775.


References
1.
de Ruiter E, Ooft M, Devriese L, Willems S . The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Oncoimmunology. 2017; 6(11):e1356148. PMC: 5674970. DOI: 10.1080/2162402X.2017.1356148. View

2.
Yuen G, Demissie E, Pillai S . B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2017; 2(12):747-757. PMC: 5472356. DOI: 10.1016/j.trecan.2016.10.010. View

3.
Zhou X, Su Y, Lao X, Liang Y, Liao G . CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol. 2015; 53:27-35. DOI: 10.1016/j.oraloncology.2015.11.003. View

4.
Castino G, Cortese N, Capretti G, Serio S, Caro G, Mineri R . Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Oncoimmunology. 2016; 5(4):e1085147. PMC: 4839336. DOI: 10.1080/2162402X.2015.1085147. View

5.
Tsou P, Katayama H, Ostrin E, Hanash S . The Emerging Role of B Cells in Tumor Immunity. Cancer Res. 2016; 76(19):5597-5601. DOI: 10.1158/0008-5472.CAN-16-0431. View